Skip to content
OpenCapital
Get started

Praxis Precision Medicines, Inc. PRAX Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One

Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One at other companies

Biogen logo
BiogenBIIB
——

Other financials

Income statement

See full
Revenue--100%
Operating income-$105.9M-41.7%
Net income-$92.6M-33.6%
EPS (diluted)-$3.20+2.7%

Balance sheet

See full
Cash & equivalents$536.7M+223%
Total debt$1.4M+31.3%
Total equity$1.4B+221%
Total assets$1.5B+205%

Cash flow

See full
Operating cash flow-$86.2M-62.5%
CapEx$62.0K—
Free cash flow-$86.2M-62.6%

Valuation

See full
Market cap$7.87B+1,075%
Enterprise value$7.34B+1,309%

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-35.3%-10.9pp
Debt / equity0×0.0×
Current ratio15.9×+7.4×

Where this comes from

Reported directly by Praxis Precision Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue.

The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Praxis Precision Medicines, Inc.'s debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Praxis Precision Medicines, Inc.'s debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one?
Praxis Precision Medicines, Inc. (PRAX) reported debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one of $250.53M in Q1 2026.
How has Praxis Precision Medicines, Inc.'s debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one changed year-over-year?
Praxis Precision Medicines, Inc.'s debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one increased by 54.2% year-over-year, from $162.42M to $250.53M.